Paper Contents
Abstract
Although the search for a novel drug delivery system (NDDS) has been ongoing for a while, it has gained steam in recent decades. Compared to the traditional dosage form, NDDS offers a number of benefits, including improved therapeutic results. Since NDDS is one method of introducing new items into the controlled market, it is also preferred in the new patent regime. Over the past few decades, a variety of NDDS have been developed, including: Aquasome, Dendrimers, Multiple Emulsions, Microemulsions, Liposomes, Niosomes, Pharmacosomes, Osmotically Modulated Drug Delivery Systems, Transdermal Therapeutic Systems (TTS), Self-Regulating Drug Delivery System, Brain Targeted Delivery System, and Nanoparticles.While another study indicated that U.S. sales of advanced drug delivery systems were over $54.2 billion in 2004 and would reach $153.5 billion by 2011, a recent analysis shows that the global market for NDDS was 37.9 billion in 2000 and would grow to 75 billion by 2005. Similar trends are being seen in India, where certain pharmaceutical companies have changed their research priorities to create NDDS. Both the public and commercial sectors in India are conducting extensive research, and the Indian market offers a variety of these items.
Copyright
Copyright © 2025 Ankush Kumar Yadav. This is an open access article distributed under the Creative Commons Attribution License.
